Is Hansoh Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Hansoh Pharmaceutical pays dividends. Last time was Wednesday 30th of October 2024 where the investors holding the stock on Friday 20th of September 2024 were paid HKD0.201 per share. Over the last 10 times between 2021 and 2024, Hansoh Pharmaceutical has paid HKD0.9188 with an average of HKD0.09 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Hansoh Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD26.10, you would have made a loss of HKD-6.22 per share or -23.83%
Yes, the average daily trading liquidity for Hansoh Pharmaceutical is HKD4.22 million. You should therefore be able to get in and out of your positions relatively fast.
Hansoh Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.72, the company's ability to pay off the debt is good. Hansoh Pharmaceutical has a very good net profit margin of 32.44% and should have very high tolerances against inflation.
We have calculated the inflation risk for Hansoh Pharmaceutical to be low [0.15 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.